SecBot SecBot
SECBOTREPLAY Home › Report › RVMDW

RVMDW · Revolution Medicines is raising $250 million through a convertible…

Revolution Medicines, Inc. · 424B5 filed Apr 13, 2026 at 16:36 ET

At the news

BEARISHIMPACT 7/10

424B5 filed Apr 13, 2026 at 16:36 ET

Revolution Medicines is raising $250 million through a convertible senior notes offering, with a concurrent $750 million common stock offering. The notes are unsecured and rank below existing secured debt, increasing financial risk.

  • Company is offering $250 million in convertible senior notes due 2033
  • Concurrent common stock offering of $750 million
  • Notes are senior unsecured obligations, structurally subordinated to subsidiary liabilities
  • Company had $268.4 million in royalty sale liabilities as of December 31, 2025

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access